# Evolocumab in Acute Coronary Syndrome

> **NCT03515304** · PHASE2 · COMPLETED · sponsor: **Johns Hopkins University** · enrollment: 60 (actual)

## Conditions studied

- Acute Coronary Syndrome

## Interventions

- **DRUG:** Evolocumab
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03515304
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-20
- **Primary completion:** 2024-10-25
- **Final completion:** 2025-03-25
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2026-05-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03515304

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03515304, "Evolocumab in Acute Coronary Syndrome". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT03515304. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*